Advertisement

Online Program, Population Health Management Combo Aids Weight Loss

0

Combo yielded greatest weight loss for obese, overweight patients over 12 months

Acute AEs With Gadolinium-Based Contrast Agents Low in Cardiac MRI

0

Acute adverse events documented in 0.36 percent of 154,779 patients

Incidence of Cerebrovascular Disease Quantified in COVID-19

0

1.4 percent of patients with COVID-19 have acute cerebrovascular disease, most often acute ischemic stroke

Higher intake of sugary beverages and artificially sweetened beverages is associated with an increased risk for cardiovascular disease

Incident CVD Up With Sugary, Artificially Sweetened Drinks

0
Risks for first incident CVD increased for higher consumers of sugary drinks, ASBs versus nonconsumers
A considerable proportion of young adults are not aware of stroke symptoms

Many U.S. Young Adults Not Aware of Stroke Symptoms

0
28.9 percent of young adults not aware of all five stroke symptoms; 2.7 percent not aware of any
Most couples are concordant in cardiovascular risk factors

Most Couples Concordant for Cardiovascular Risk

0
In 79 percent of couples, both members are in nonideal category for cardiovascular health score

American College of Chest Physicians, Oct. 18-21

0
The 86th Annual Meeting of the American College of Chest Physicians The annual meeting of the American College of Chest Physicians was held...
There was a decrease in the frequency of hospitalizations for non-COVID-19-related conditions during the COVID-19 pandemic and in the caseloads of common medical emergencies

Decrease Seen in Non-COVID-19-Related Hospitalizations at Peak

0
Caseload of common medical emergencies, including acute MI, ischemic stroke also decreased
Homeless individuals are more likely to die from heart attacks while being treated at a hospital than nonhomeless patients

In-Hospital Mortality Higher for Homeless Heart Attack Patients

0
Risk for death three times higher for homeless, despite receiving similar care
Finerenone results in a lower risk for chronic kidney disease (CKD) progression in patients with CKD and type 2 diabetes

ASN: Finerenone May Slow Progression in CKD With T2DM

0
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo